Shanghai Yizhong Pharmaceutical Co (SHSE:688091) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688091 Shanghai Yizhong Pharmaceutical Co Ltd SHSE:688091
60 GF Score
Price ¥40.86
GF Value ¥50.51
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shanghai Yizhong Pharmaceutical Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHSE:688091
60GF Score
Shanghai Yizhong Pharmaceutical Co Ltd SHSE:688091
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Shanghai Yizhong Pharmaceutical Co (SHSE:688091) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Yizhong Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥40.86 is trading 19.1% below its estimated GF Value™ of ¥50.51. GuruFocus considers Shanghai Yizhong Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688091:

  • Dividends Received:
  • GF Value™: ¥50.51 vs. price of ¥40.86 (19.1% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the SHSE:688091 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Yizhong Pharmaceutical Co Business Description

Address 79 Renqi Road, Fengxian District, Shanghai, CHN, 201403
Shanghai Yizhong Pharmaceutical Co Ltd is a pharmaceutical enterprise integrating research and development, production and sales. It is committed towards the development of new dosage forms of anti-tumor drugs and related products.
60GF Score

Get the complete analysis for SHSE:688091

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥40.86
Price
¥50.51
GF Value